250 related articles for article (PubMed ID: 36792381)
1. Repurposing ketamine to treat cocaine use disorder: integration of artificial intelligence-based prediction, expert evaluation, clinical corroboration and mechanism of action analyses.
Gao Z; Winhusen TJ; Gorenflo M; Ghitza UE; Davis PB; Kaelber DC; Xu R
Addiction; 2023 Jul; 118(7):1307-1319. PubMed ID: 36792381
[TBL] [Abstract][Full Text] [Related]
2. Potential effect of antidepressants on remission from cocaine use disorder - A nationwide matched retrospective cohort study.
Gao Z; Winhusen TJ; Gorenflo M; Ghitza UE; Nunes E; Saxon AJ; Korthuis T; Brady K; Luo SX; Davis PB; Kaelber DC; Xu R
Drug Alcohol Depend; 2023 Oct; 251():110958. PubMed ID: 37703770
[TBL] [Abstract][Full Text] [Related]
3. Drug repurposing for opioid use disorders: integration of computational prediction, clinical corroboration, and mechanism of action analyses.
Zhou M; Wang Q; Zheng C; John Rush A; Volkow ND; Xu R
Mol Psychiatry; 2021 Sep; 26(9):5286-5296. PubMed ID: 33432189
[TBL] [Abstract][Full Text] [Related]
4. Ketamine administration in depressive disorders: a systematic review and meta-analysis.
Fond G; Loundou A; Rabu C; Macgregor A; Lançon C; Brittner M; Micoulaud-Franchi JA; Richieri R; Courtet P; Abbar M; Roger M; Leboyer M; Boyer L
Psychopharmacology (Berl); 2014 Sep; 231(18):3663-76. PubMed ID: 25038867
[TBL] [Abstract][Full Text] [Related]
5. Beta-caryophyllene inhibits cocaine addiction-related behavior by activation of PPARα and PPARγ: repurposing a FDA-approved food additive for cocaine use disorder.
Galaj E; Bi GH; Moore A; Chen K; He Y; Gardner E; Xi ZX
Neuropsychopharmacology; 2021 Mar; 46(4):860-870. PubMed ID: 33069159
[TBL] [Abstract][Full Text] [Related]
6. Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder.
Dean RL; Marquardt T; Hurducas C; Spyridi S; Barnes A; Smith R; Cowen PJ; McShane R; Hawton K; Malhi GS; Geddes J; Cipriani A
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD011611. PubMed ID: 34623633
[TBL] [Abstract][Full Text] [Related]
7. Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults.
McCloud TL; Caddy C; Jochim J; Rendell JM; Diamond PR; Shuttleworth C; Brett D; Amit BH; McShane R; Hamadi L; Hawton K; Cipriani A
Cochrane Database Syst Rev; 2015 Sep; (9):CD011611. PubMed ID: 26415966
[TBL] [Abstract][Full Text] [Related]
8. Ketamine: The final frontier or another depressing end?
Sial OK; Parise EM; Parise LF; Gnecco T; Bolaños-Guzmán CA
Behav Brain Res; 2020 Apr; 383():112508. PubMed ID: 32017978
[TBL] [Abstract][Full Text] [Related]
9. Association of semaglutide with reduced incidence and relapse of cannabis use disorder in real-world populations: a retrospective cohort study.
Wang W; Volkow ND; Berger NA; Davis PB; Kaelber DC; Xu R
Mol Psychiatry; 2024 Mar; ():. PubMed ID: 38486046
[TBL] [Abstract][Full Text] [Related]
10. Ketamine Tolerance in Sprague-Dawley Rats after Chronic Administration of Ketamine, Morphine, or Cocaine.
Gerb SA; Cook JE; Gochenauer AE; Young CS; Fulton LK; Grady AW; Freeman KB
Comp Med; 2019 Feb; 69(1):29-34. PubMed ID: 30696519
[TBL] [Abstract][Full Text] [Related]
11. Study protocol for Ketamine as an adjunctive therapy for major depression (2): a randomised controlled trial (KARMA-Dep [2]).
Jelovac A; McCaffrey C; Terao M; Shanahan E; Mohamed E; Whooley E; McDonagh K; McDonogh S; Igoe A; Loughran O; Shackleton E; O'Neill C; McLoughlin DM
BMC Psychiatry; 2023 Nov; 23(1):850. PubMed ID: 37974160
[TBL] [Abstract][Full Text] [Related]
12. Ketamine and other glutamate receptor modulators for depression in adults.
Caddy C; Amit BH; McCloud TL; Rendell JM; Furukawa TA; McShane R; Hawton K; Cipriani A
Cochrane Database Syst Rev; 2015 Sep; (9):CD011612. PubMed ID: 26395901
[TBL] [Abstract][Full Text] [Related]
13. Repurposing of Drugs-The Ketamine Story.
Das J
J Med Chem; 2020 Nov; 63(22):13514-13525. PubMed ID: 32915563
[TBL] [Abstract][Full Text] [Related]
14. Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder.
Dean RL; Hurducas C; Hawton K; Spyridi S; Cowen PJ; Hollingsworth S; Marquardt T; Barnes A; Smith R; McShane R; Turner EH; Cipriani A
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD011612. PubMed ID: 34510411
[TBL] [Abstract][Full Text] [Related]
15. Medical complications associated with substance use disorders in patients with type 2 diabetes and hypertension: electronic health record findings.
Winhusen T; Theobald J; Kaelber DC; Lewis D
Addiction; 2019 Aug; 114(8):1462-1470. PubMed ID: 30851217
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial.
Dwyer JB; Landeros-Weisenberger A; Johnson JA; Londono Tobon A; Flores JM; Nasir M; Couloures K; Sanacora G; Bloch MH
Am J Psychiatry; 2021 Apr; 178(4):352-362. PubMed ID: 33653121
[TBL] [Abstract][Full Text] [Related]
17. Application of antidepressants in depression: A systematic review and meta-analysis.
Yuan Z; Chen Z; Xue M; Zhang J; Leng L
J Clin Neurosci; 2020 Oct; 80():169-181. PubMed ID: 33099342
[TBL] [Abstract][Full Text] [Related]
18. A Single Ketamine Infusion Combined With Mindfulness-Based Behavioral Modification to Treat Cocaine Dependence: A Randomized Clinical Trial.
Dakwar E; Nunes EV; Hart CL; Foltin RW; Mathew SJ; Carpenter KM; Choi CJJ; Basaraba CN; Pavlicova M; Levin FR
Am J Psychiatry; 2019 Nov; 176(11):923-930. PubMed ID: 31230464
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of
Zhu Y; Zhao Y; Xu X; Su H; Li X; Zhong N; Jiang H; Du J; Zhao M
Gen Psychiatr; 2021; 34(5):e100587. PubMed ID: 34723091
[TBL] [Abstract][Full Text] [Related]
20. Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant.
Kokane SS; Armant RJ; Bolaños-Guzmán CA; Perrotti LI
Behav Brain Res; 2020 Apr; 384():112548. PubMed ID: 32061748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
